Alpha 2.0
Login Register
» Articles » PMID: 35702859

Immunogenicity and Clinical Efficacy of Anti-SARS-CoV-2 Vaccination in Patients with Hematological Malignancies: Results of a Prospective Cohort Study of 365 Patients

Overview
Journal Am J Hematol
Specialty Hematology
Date 2022 Jun 15
PMID 35702859
Authors
Marco Salvini
Camilla Damonte
Lorenzo Mortara
Fabrizio Maggi
Antonino Bruno
Giacomo Pellegrini
Barbara Mora
Marco Brociner
Alessia Ingrassia
Roberta Mattarucchi
Benedetta Bianchi
Davide Sirocchi
Stefania Agnoli
Elisa Rumi
Michele Merli
Alessandro Fossati
Susanna Bassi
Raffaella Bombelli
Matteo Gallazzi
Oscar Borsani
Andreina Baj
Matteo Franchi
Paolo A Grossi
Francesco Passamonti
Affiliations
Soon will be listed here.
Citing Articles

Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects.

Laquintana V, Mottini C, Marchesi F, Marcozzi B, Terrenato I, Sperandio E Front Immunol. 2024; 14:1221587.

PMID: 38343436 PMC: 10853639. DOI: 10.3389/fimmu.2023.1221587.

COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?.

Harel R, Itchaki G Acta Haematol. 2023; 147(1):60-72.

PMID: 37820599 PMC: 11251671. DOI: 10.1159/000534540.

Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study.

Oliva A, Cogliati Dezza F, Petrucci F, Romani F, Morviducci M, Mirabelli F Clin Exp Med. 2023; 23(6):2275-2285.

PMID: 36867292 PMC: 9982764. DOI: 10.1007/s10238-023-01027-y.

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.

Pagano L, Salmanton-Garcia J, Marchesi F, Blennow O, Gomes Da Silva M, Glenthoj A Blood. 2022; 140(26):2773-2787.

PMID: 36126318 PMC: 9492383. DOI: 10.1182/blood.2022017257.

References
1.
Passamonti F, Cattaneo C, Arcaini L, Bruna R, Cavo M, Merli F . Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020; 7(10):e737-e745. PMC: 7426107. DOI: 10.1016/S2352-3026(20)30251-9. View
2.
Salvini M, Maggi F, Damonte C, Mortara L, Bruno A, Mora B . Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation. Bone Marrow Transplant. 2021; 57(1):137-139. PMC: 8504426. DOI: 10.1038/s41409-021-01487-4. View